Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.

Abstract	An attempt was made to study the immunoprophylactic efficacy of recombinant Brugia malayi transglutaminase (BmTGA) as protein vaccine along with two other recombinant proteins, Brugia malayi abundant larval transcript-2 (BmALT-2) and Brugia malayi thioredoxin peroxidase (BmTPX), in single and multiple antigen form for human lymphatic filariasis. Parasite challenge studies in jirds exhibited protection of 30%, 69%, and 43% against BmTGA, BmALT-2, and BmTPX, respectively, in single antigen vaccination mode. The protective efficacy of BmTGA was enhanced significantly (74%) by immunizing the jirds in multiple antigen vaccination mode along with BmTPX, whereas immunizing with the combination of BmTGA and BmALT2 conferred only 47% protection. The same protection profiles were obtained by in vitro antibody-dependent cellular cytotoxicity, using live microfilariae and L3 stage larvae. The immune response was Th2 biased, irrespective of single or multiple vaccinations. The combination of BmTGA and BmTPX seems to be a promising vaccine candidate against lymphatic filariasis.
Authors	Uma Vanam, Vivek Pandey, Prince R Prabhu, Gajalakshmi Dakshinamurthy, Maryada Venkata Rami Reddy, Perumal Kaliraj
Journal	The American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 80 Issue 2 Pg. 319-24 (Feb 2009) ISSN: 1476-1645 [Electronic] United States
PMID	19190232 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	ALT-2 protein, Brugia malayi Antibodies, Helminth Antigens, Helminth Recombinant Proteins Vaccines Vaccines, DNA Peroxiredoxins Transglutaminases
Topics	Animals Antibodies, Helminth (blood) Antigens, Helminth (genetics, immunology) Brugia malayi (genetics, immunology, pathogenicity) Elephantiasis, Filarial (immunology, parasitology, prevention & control) Gerbillinae Humans Male Peroxiredoxins (genetics, immunology) Recombinant Proteins (genetics, immunology) Transglutaminases (genetics, immunology) Treatment Outcome Vaccines (administration & dosage, genetics, immunology) Vaccines, DNA (administration & dosage, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!